15 December 2023>: Original Paper
Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Preformed Donor-Specific Antibodies: A Single-Center Experience
Masato Shizuku 123ABCDEF , Nobuhiko Kurata 1B , Kanta Jobara 1B , Yasuhiro Fujimoto 1B , Yasuhiro Ogura 1ABCDFG*DOI: 10.12659/AOT.941456
Ann Transplant 2023; 28:e941456
Figure 3 Kaplan-Meier curve for the overall survival of patients in the rituximab (+) and rituximab (−) groups and patients without pDSA. LTx – liver transplantation; pDSA – preformed donor-specific antibody.